Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 477 articles:
HTML format



Single Articles


    December 2022
  1. TESCH ME, Rosenberg SM, Collins LC, Wong JS, et al
    ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:8058-8059.
    PubMed    


  2. WILLIAMS AD, Khan AJ, Sevilimedu V, Barrio AV, et al
    ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
    Ann Surg Oncol. 2022;29:8046-8047.
    PubMed    


  3. WOODS AP, Papageorge MV, de Geus SWL, Alonso A, et al
    ASO Visual Abstract: Impact of Patient Primary Language upon Immediate Breast Reconstruction after Mastectomy.
    Ann Surg Oncol. 2022;29:8621-8622.
    PubMed    


  4. TESCH ME, Rosenberg SM, Collins LC, Wong JS, et al
    Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:8048-8057.
    PubMed     Abstract available


  5. WILLIAMS AD, Khan AJ, Sevilimedu V, Barrio AV, et al
    Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
    Ann Surg Oncol. 2022;29:8037-8043.
    PubMed     Abstract available


  6. WOODS AP, Papageorge MV, de Geus SWL, Alonso A, et al
    Impact of Patient Primary Language upon Immediate Breast Reconstruction After Mastectomy.
    Ann Surg Oncol. 2022;29:8610-8618.
    PubMed     Abstract available


  7. ROBBINS T, Hoskin TL, Day CN, Mrdutt MM, et al
    ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.
    Ann Surg Oncol. 2022;29.
    PubMed    


  8. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
    ASO Visual Abstract: Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
    Ann Surg Oncol. 2022;29.
    PubMed    


  9. ABBASSI-RAHBAR S, Amin AL
    ASO Author Reflections: De-escalation of Surgical Excision for Intraductal Papilloma of the Breast.
    Ann Surg Oncol. 2022;29.
    PubMed    


  10. LIM DW, Hong NJL
    ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Ann Surg Oncol. 2022;29.
    PubMed    


  11. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
    ASO Author Reflections: Improving Management of Upper Limb Complications after Breast Cancer Treatments.
    Ann Surg Oncol. 2022;29.
    PubMed    


  12. LEILOGLOU M, Kedrzycki MS, Elson DS, Leff DR, et al
    ASO Author Reflections: Towards Fluorescence Guided Tumor Identification for Precision Breast Conserving Surgery.
    Ann Surg Oncol. 2022;29.
    PubMed    


  13. GARSTKA M, Smith BL
    ASO Author Reflections: Prophylactic Nipple-Sparing Mastectomy as an Effective Risk-Reducing Strategy for BRCA Mutation Carriers.
    Ann Surg Oncol. 2022;29.
    PubMed    


  14. THOMPSON J, Wright GP
    ASO Author Reflections: Overtreatment of Older Females with Favorable-Prognosis Breast Cancer.
    Ann Surg Oncol. 2022;29.
    PubMed    


  15. ELSHERIF A, Valente SA
    ASO Author Reflections: Is Cefazolin Enough with Implant Reconstruction? Does Retaining the Nipple Make a Difference?
    Ann Surg Oncol. 2022;29.
    PubMed    


  16. BOUGHEY JC, Nguyen TT, Dietz JR, Wilke LG, et al
    ASO Authors Reflection: Lessons Learned from the COVID-19 Pandemic-Should We Change Surgical Management of Patients with Breast Cancer?
    Ann Surg Oncol. 2022;29.
    PubMed    


  17. CHAGPAR AB
    ASO Author Reflections: "Right-Sizing" Radiation Therapy After Mastectomy.
    Ann Surg Oncol. 2022;29.
    PubMed    


  18. COCCO D, Valente SA
    ASO Author Reflection: Updating our Knowledge on Invasive Lobular Breast Cancer.
    Ann Surg Oncol. 2022;29.
    PubMed    


    November 2022
  19. SBROCCHI T, Kavanagh K, Chao AH
    Optimizing the Timeliness of Surgical Therapy in Patients with Breast Cancer Undergoing Immediate Breast Reconstruction.
    Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12835.
    PubMed     Abstract available


  20. SUN SX, Duan Z, Kuerer HM, DeSnyder SM, et al
    Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population.
    Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12836.
    PubMed     Abstract available


  21. NAKAMURA S
    Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Potential Benefit of a New Target.
    Ann Surg Oncol. 2022 Nov 18. doi: 10.1245/s10434-022-12329.
    PubMed    


  22. CHAO AH
    ASO Author Reflections: Refining the Integration of Reconstructive Surgery into Breast Cancer Care.
    Ann Surg Oncol. 2022 Nov 18. doi: 10.1245/s10434-022-12842.
    PubMed    


  23. KO G, Hallet J, Jerzak KJ, Chan W, et al
    ASO Visual Abstract: Low Rates of Medical Oncology Consultation for Older Women (>/= 70 Years) with Newly Diagnosed, Nonmetastatic Breast Cancer-a Population-Based Study.
    Ann Surg Oncol. 2022 Nov 14. pii: 10.1245/s10434-022-12727.
    PubMed    


  24. OH SJ, Butler PD
    Ensuring Both Accessibility and Usability of Breast Cancer Care.
    Ann Surg Oncol. 2022 Nov 7. pii: 10.1245/s10434-022-12763.
    PubMed    


  25. SCHWARTZ T, Marumoto AD, Giuliano AE
    ASO Visual Abstract: Surgical Management of the Axilla in Breast Cancer-Evolving but Still Necessary.
    Ann Surg Oncol. 2022 Nov 5. pii: 10.1245/s10434-022-12685.
    PubMed    


  26. KNAPE N, Park JH, Agala CB, Spanheimer P, et al
    ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women >/=50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
    Ann Surg Oncol. 2022 Nov 4. pii: 10.1245/s10434-022-12726.
    PubMed    


  27. GOOIJER SA, Folkersma C, van Steenhoven JEC, de Kort J, et al
    Long-Term Outcome of Sustained Endocrine Monotherapy for Elderly Breast Cancer Patients.
    Ann Surg Oncol. 2022 Nov 3. pii: 10.1245/s10434-022-12662.
    PubMed     Abstract available


  28. PESTANA CV, Livasy CA, Donahue EE, Neelands B, et al
    ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022;29:7725.
    PubMed    


  29. FAN B, James T
    Avoiding Axillary Management Pitfalls After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2022;29:7265-7266.
    PubMed    


  30. PILTIN MA, Hoskin TL, Day CN, Habermann EB, et al
    ASO Visual Abstract: Overuse of Axillary Surgery for Patients With Ductal Carcinoma In Situ: Opportunity for De-Escalation.
    Ann Surg Oncol. 2022;29:7715.
    PubMed    


  31. KIM YS, Cho HG, Kim J, Park SJ, et al
    ASO Visual Abstract: Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurement and Breast MRI.
    Ann Surg Oncol. 2022;29:7857-7858.
    PubMed    


  32. NICKEL KB, Myckatyn TM, Lee CN, Fraser VJ, et al
    ASO Visual Abstract: Individualized Risk Prediction Tool for Serious Wound Complications after Mastectomy with and without Immediate Reconstruction.
    Ann Surg Oncol. 2022;29:7767-7768.
    PubMed    


  33. NICKEL KB, Myckatyn TM, Lee CN, Fraser VJ, et al
    Individualized Risk Prediction Tool for Serious Wound Complications After Mastectomy With and Without Immediate Reconstruction.
    Ann Surg Oncol. 2022;29:7751-7764.
    PubMed     Abstract available


  34. OLSEN MA, Myckatyn TM, Lee CN
    ASO Author Reflections: Need for Individualized Risk Prediction to Facilitate Shared Decision Making in Post-mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2022;29:7765-7766.
    PubMed    


  35. PESTANA CV, Livasy CA, Donahue EE, Neelands B, et al
    Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022;29:7716-7724.
    PubMed     Abstract available


  36. ABEL MK, Mukhtar RA
    ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.
    Ann Surg Oncol. 2022;29:7748-7749.
    PubMed    


  37. PILTIN MA, Hoskin TL, Day CN, Habermann EB, et al
    Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation.
    Ann Surg Oncol. 2022;29:7705-7712.
    PubMed     Abstract available


  38. KIM YS, Cho HG, Kim J, Park SJ, et al
    Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurements and Breast MRI.
    Ann Surg Oncol. 2022;29:7845-7854.
    PubMed     Abstract available


  39. KIM YS, Cho HG, Kim J, Park SJ, et al
    ASO Author Reflections: Prediction of Implant Size Based on Breast Volumetry Using Mammography and Breast MRI in DTI Breast Reconstruction.
    Ann Surg Oncol. 2022;29:7855-7856.
    PubMed    


  40. CULVER JO, Freiberg Y, Ricker C, Comeaux JG, et al
    ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
    Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12712.
    PubMed    


    October 2022
  41. KO G, Wright FC, Look Hong NJ
    ASO Author Reflections: Why Are Older Women with Breast Cancer Receiving Substandard Care? An Analysis of Consultation Patterns.
    Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12747.
    PubMed    


  42. FAYANJU OM, Edmonds CE, Reyes SA, Arciero C, et al
    ASO Visual Abstract: Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.
    Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12665.
    PubMed    


  43. KO G, Hallet J, Jerzak KJ, Chan W, et al
    Low Rates of Medical Oncology Consultation for Older Women (>/= 70 Years) with Newly Diagnosed, Non-Metastatic Breast Cancer: A Population-Based Study.
    Ann Surg Oncol. 2022 Oct 18. pii: 10.1245/s10434-022-12640.
    PubMed     Abstract available


  44. KHAN SY, Melkus MW, Layeequr Rahman R
    ASO Author Reflections: Cryoablation Cost-Benefit Analysis: Managing Breast Cancer Through Cost-Effective Therapy.
    Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12669.
    PubMed    


  45. SCHWARTZ T, Marumoto AD, Giuliano AE
    ASO Author Reflections: The Evolution of Axillary Management in Breast Cancer.
    Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12677.
    PubMed    


  46. CULVER JO
    ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Oct 14. pii: 10.1245/s10434-022-12671.
    PubMed    


  47. POSTLEWAIT LM
    Assessment of Novel Therapeutics for Individualized Breast Cancer Care in the Modern Era: The Role of Metformin in Breast Cancer Therapy.
    Ann Surg Oncol. 2022 Oct 12. pii: 10.1245/s10434-022-12627.
    PubMed    


  48. KNAPE N, Park JH, Agala CB, Spanheimer P, et al
    Can We Forgo Sentinel Lymph Node Biopsy in Women Aged >/= 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
    Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12626.
    PubMed     Abstract available


  49. HASSAN AM, Offodile AC 2nd
    ASO Author Reflections: Neighborhood-Level Deprivation Impacts Patient-Reported Outcomes Following Breast Cancer Surgery.
    Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12521.
    PubMed    


  50. MURPHY BL, Yi M, Barrera AG, Tripathy D, et al
    ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
    Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12519.
    PubMed    


  51. SAHA D, Balasubramanian A, Kannan A, Pant A, et al
    Breast Cancer Screening in Young Women with the Advent of Newer Techniques: Current Evidence and Future Considerations.
    Ann Surg Oncol. 2022 Oct 8. pii: 10.1245/s10434-022-12550.
    PubMed    


  52. PALMQUIST E, Limberg J, Chu JJ, White C, et al
    ASO Visual Abstract: Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy With and Without Reconstruction.
    Ann Surg Oncol. 2022 Oct 7. pii: 10.1245/s10434-022-12585.
    PubMed     Abstract available


  53. ESCOBAR N, Joseph KA
    ASO Author Reflections: Same but Different: Implications of Surgical Delays for Breast Cancer Patients Treated in NYC Public Hospitals During the COVID-19 Pandemic.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12540.
    PubMed    


  54. KAPP KA, Cheng AL, Bruton CM, Ahmadiyeh N, et al
    ASO Visual Abstract: Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12475.
    PubMed    


  55. SCHWARTZ T, Marumoto AD, Giuliano AE
    Surgical Management of the Axilla in Breast Cancer: Evolving but Still Necessary.
    Ann Surg Oncol. 2022 Oct 4. pii: 10.1245/s10434-022-12605.
    PubMed    


  56. FAYANJU OM, Edmonds CE, Reyes SA, Arciero C, et al
    The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.
    Ann Surg Oncol. 2022 Oct 3. pii: 10.1245/s10434-022-12535.
    PubMed     Abstract available


  57. KHAN SY, Snitman A, Habrawi Z, Crawford S, et al
    ASO Visual Abstract: The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient Reported Outcomes.
    Ann Surg Oncol. 2022 Oct 2. pii: 10.1245/s10434-022-12610.
    PubMed    


  58. CHAKEDIS JM, Tang A, Savitz A, Lyon LL, et al
    ASO Visual Abstract: Economic Impact of Reducing Re-excision Rates After Breast-Conserving Surgery in a Large, Integrated Health System.
    Ann Surg Oncol. 2022;29:6297-6298.
    PubMed    


  59. ABUJBARAH S, Jogerst K, Kosiorek HE, Ahmad S, et al
    ASO Visual Abstract: Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?
    Ann Surg Oncol. 2022;29:6406.
    PubMed    


  60. MARTINEZ EO, Jorns JM, Kong AL, Kijak J, et al
    ASO Visual Abstract: Primary Breast Neuroendocrine Tumors-An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022;29:6349.
    PubMed    


  61. NANDA AD, Reifel KR, Mann MP, Lyman-Hager MM, et al
    Text-Based Intervention Increases Mammography Uptake at an Urban Safety-Net Hospital.
    Ann Surg Oncol. 2022;29:6199-6205.
    PubMed     Abstract available


  62. MONTAGNA G, Morrow M
    ASO Author Reflections: Do We Need to Clip Metastatic Lymph Nodes at Diagnosis and Localize Them After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022;29:6140-6141.
    PubMed    


  63. MILLER KN, Thomas SM, Sergesketter AR, Rosenberger LH, et al
    The Influence of Body Mass Index on the Histopathology and Outcomes of Patients Diagnosed with Atypical Breast Lesions.
    Ann Surg Oncol. 2022;29:6484-6494.
    PubMed     Abstract available


  64. JOGERST KM, Abujbarah SM, Pockaj B
    ASO Author Reflections: Weighing the Risks and Benefits of Multimodal Analgesia Following Breast Surgery.
    Ann Surg Oncol. 2022;29:6404-6405.
    PubMed    


  65. HIEKEN TJ, Solanki MH
    ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
    Ann Surg Oncol. 2022;29:6466-6467.
    PubMed    


  66. OROZCO JIJ, Le J, Baker JL, Marzese DM, et al
    ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.
    Ann Surg Oncol. 2022;29:6415-6416.
    PubMed    


  67. MARTINS RS, Sattar AK
    ASO Author Reflections: Perioperative Antibiotic Prophylaxis for Mastectomy-Too Much or Too Little.
    Ann Surg Oncol. 2022;29:6323-6324.
    PubMed    


  68. DIEGO EJ, Rosenberger LH, Deng X, McGuire KP, et al
    ASO Visual Abstract: Margin Management and Adjuvant Therapy for Phyllodes Tumors-Practice Patterns of the American Society of Breast Surgeons Members.
    Ann Surg Oncol. 2022;29:6162.
    PubMed    


  69. SATTAR AK, Shahzad H, Masroor T, Martins RS, et al
    ASO Visual Abstract: Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy-A Survey of Members of the American Society of Breast Surgeons.
    Ann Surg Oncol. 2022;29:6325-6326.
    PubMed    


  70. CHAKEDIS JM, Tang A, Savitz A, Lyon LL, et al
    Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System.
    Ann Surg Oncol. 2022;29:6288-6296.
    PubMed     Abstract available


  71. SATTAR AK, Shahzad H, Masroor T, Martins RS, et al
    Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy: A Survey of Members of the American Society of Breast Surgeons.
    Ann Surg Oncol. 2022;29:6314-6322.
    PubMed     Abstract available


  72. DE LA CRUZ KU G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, et al
    Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients.
    Ann Surg Oncol. 2022;29:6163-6188.
    PubMed     Abstract available


  73. SANDERS SB, Hoskin TL, Solanki MH, Stafford AP, et al
    ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2022;29:6468.
    PubMed    


  74. CRARY IL, Parker EU, Lowry KP, Patwardhan PP, et al
    ASO Visual Abstract: Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma.
    Ann Surg Oncol. 2022;29:6360.
    PubMed    


  75. TELLER P, Nguyen TT, Tseng J, Allen L, et al
    Innovation in Breast Surgery: Practical and Ethical Considerations.
    Ann Surg Oncol. 2022;29:6144-6150.
    PubMed     Abstract available


  76. ROBBINS T, Hoskin TL, Day CN, Mrdutt MM, et al
    Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.
    Ann Surg Oncol. 2022;29:6276-6287.
    PubMed     Abstract available


  77. ABUJBARAH SM, Jogerst K, Kosiorek HE, Ahmad S, et al
    Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?
    Ann Surg Oncol. 2022;29:6395-6403.
    PubMed     Abstract available


  78. A DE LA CRUZ-KU G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, et al
    ASO Visual Abstract: Does Breast-Conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-Analysis of More Than 1,500,000 Patients.
    Ann Surg Oncol. 2022;29:6197-6198.
    PubMed    


  79. DIEGO EJ, Rosenberger LH, Deng X, McGuire KP, et al
    Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members.
    Ann Surg Oncol. 2022;29:6151-6161.
    PubMed     Abstract available


  80. SANDERS SB, Hoskin TL, Solanki MH, Stafford AP, et al
    Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2022;29:6458-6465.
    PubMed     Abstract available


  81. ZHANG C, Kosiorek HE, Patel BK, Pockaj BA, et al
    Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
    Ann Surg Oncol. 2022;29:6207-6212.
    PubMed     Abstract available


  82. CRARY IL, Flanagan MR
    ASO Author Reflections: Is Surgical Excision Necessary in Lobular Neoplasia with Synchronous Breast Carcinoma?
    Ann Surg Oncol. 2022;29:6359.
    PubMed    


  83. GENTLE CK, Pratt DA
    ASO Author Reflections: It is Time to Deescalate Screening Mammography for Patients Who Do Not Benefit.
    Ann Surg Oncol. 2022;29:6367-6368.
    PubMed    


  84. CRARY IL, Parker EU, Lowry KP, Patwardhan PP, et al
    Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma.
    Ann Surg Oncol. 2022;29:6350-6358.
    PubMed     Abstract available


  85. MARTINEZ EO, Jorns JM, Kong AL, Kijak J, et al
    Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022;29:6339-6346.
    PubMed     Abstract available


  86. PARK HS, Lee J, Lai HW, Park JM, et al
    ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis.
    Ann Surg Oncol. 2022;29:6658-6659.
    PubMed    


  87. PAK LM, Pawloski KR, Sevilimedu V, Kalvin HL, et al
    ASO Visual Abstract: How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy.
    Ann Surg Oncol. 2022;29:6714-6715.
    PubMed    


  88. ZAVERI S, Romanoff A
    ASO Author Reflections on "Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center".
    Ann Surg Oncol. 2022;29:6704.
    PubMed    


  89. JOUKAINEN S, Laaksonen E, Vanninen R, Kaarela O, et al
    Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique.
    Ann Surg Oncol. 2022;29:6716-6727.
    PubMed     Abstract available


  90. FERROUM A, Wong SM
    ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy.
    Ann Surg Oncol. 2022;29:6669-6670.
    PubMed    


  91. PAK LM, Pawloski KR, Sevilimedu V, Kalvin HL, et al
    How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy.
    Ann Surg Oncol. 2022;29:6706-6713.
    PubMed     Abstract available


  92. ZAVERI S, Nevid D, Ru M, Moshier E, et al
    Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center.
    Ann Surg Oncol. 2022;29:6692-6703.
    PubMed     Abstract available


  93. PARK HS, Lee J, Lai HW, Park JM, et al
    Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis.
    Ann Surg Oncol. 2022;29:6646-6657.
    PubMed     Abstract available


    September 2022
  94. KHAN SY, Snitman A, Habrawi Z, Crawford S, et al
    The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient-Reported Outcomes.
    Ann Surg Oncol. 2022 Sep 28. pii: 10.1245/s10434-022-12570.
    PubMed     Abstract available


  95. KANTOR O, Dominici L
    Recognizing Disparities in Breast Cancer Patient-Reported Outcome Measures.
    Ann Surg Oncol. 2022 Sep 27. pii: 10.1245/s10434-022-12537.
    PubMed    


  96. ESCOBAR N, DiMaggio C, Pocock B, Pescovitz A, et al
    ASO Visual Abstract: An Analysis of COVID-19 on Surgical Delays in Breast Cancer Patients in NYC Public Hospitals-A Multicenter Study.
    Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12609.
    PubMed    


  97. CULVER JO, Freiberg Y, Ricker C, Comeaux JG, et al
    Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
    Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12595.
    PubMed     Abstract available


  98. PALMQUIST E, Limberg J, Chu JJ, White C, et al
    Patient-Reported Outcome Measures for Patients Who Have Clinical T4 Breast Cancer Treated via Mastectomy with and Without Reconstruction.
    Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12560.
    PubMed     Abstract available


  99. SROUR MK, Tadros AB, Sevilimedu V, Nelson JA, et al
    Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage?
    Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12477.
    PubMed     Abstract available


  100. CROWN A, Joseph KA
    ASO Author Reflections: Optimizing Breast Cancer Risk Assessment and Screening Among Black Women.
    Ann Surg Oncol. 2022 Sep 22. pii: 10.1245/s10434-022-12586.
    PubMed    


  101. MAGNONI F, Corso G
    ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer?
    Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12589.
    PubMed    


  102. HASSAN AM, Nguyen HT, Corkum JP, Liu J, et al
    ASO Visual Abstract: The Area Deprivation Index is Associated with Variation in Quality of Life and Psychosocial Well-being After Breast Cancer Surgery.
    Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12554.
    PubMed    


  103. ESCOBAR N, DiMaggio C, Pocock B, Pescovitz A, et al
    Effects of COVID-19 on Surgical Delays in Patients with Breast Cancer in NYC Public Hospitals: A Multicenter Study.
    Ann Surg Oncol. 2022 Sep 15. pii: 10.1245/s10434-022-12491.
    PubMed     Abstract available


  104. CORSO G, Magnoni F, Veronesi P
    Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer.
    Ann Surg Oncol. 2022 Sep 15. pii: 10.1245/s10434-022-12542.
    PubMed     Abstract available


  105. COBB AN, Diao K, Teshome M, Lucci A, et al
    ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
    Ann Surg Oncol. 2022 Sep 14. pii: 10.1245/s10434-022-12457.
    PubMed    


  106. SROUR MK, Tadros AB, Sevilimedu V, Nelson JA, et al
    ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage?
    Ann Surg Oncol. 2022 Sep 13. pii: 10.1245/s10434-022-12511.
    PubMed    


  107. MURPHY BL, Yi M, Gutierrez Barrera AM, Tripathy D, et al
    Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
    Ann Surg Oncol. 2022 Sep 12. pii: 10.1245/s10434-022-12468.
    PubMed     Abstract available


  108. HASSAN AM, Nguyen HT, Corkum JP, Liu J, et al
    Area Deprivation Index is Associated with Variation in Quality of Life and Psychosocial Well-being Following Breast Cancer Surgery.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12506.
    PubMed     Abstract available


  109. NAIR AG, Giannakeas V, Semple JL, Narod SA, et al
    Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Sep 8. pii: 10.1245/s10434-022-12408.
    PubMed     Abstract available


  110. NAIR AG, Giannakeas V, Semple JL, Narod SA, et al
    ASO Visual Abstract: Contemporary Trends in Breast Reconstruction Use and Impact on Survival Amongst Women with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Sep 7. pii: 10.1245/s10434-022-12458.
    PubMed    


  111. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
    ASO Visual Abstract: Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery: A Rare Complication and a Proposed Management Strategy from the British and Italian Experience.
    Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12412.
    PubMed    


  112. SROUR MK, Tadros AB, Morrow M
    ASO Author Reflections: Engagement in Patient-Reported Outcomes for Breast Cancer.
    Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12481.
    PubMed    


  113. ELDER EA, Livasy CA, Donahue EE, Neelands B, et al
    ASO Visual Abstract: Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12429.
    PubMed    


  114. KIM LS, Park T, Berger ER, Golshan M, et al
    Editorial Comment on: One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol.
    Ann Surg Oncol. 2022;29:5361-5363.
    PubMed    


  115. CARLETON N, Oesterreich S, Marroquin OC, Diego EJ, et al
    Is the Choosing Wisely Recommendation for Omission of Sentinel Lymph Node Biopsy Applicable for Invasive Lobular Carcinoma?
    Ann Surg Oncol. 2022;29:5379-5382.
    PubMed    


  116. CORSO G, Robson ME, Sacchini V
    Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers.
    Ann Surg Oncol. 2022;29:5821-5825.
    PubMed     Abstract available


  117. LILLEMOE HA, Miranda RN, Nastoupil LJ, Clemens MW, et al
    Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
    Ann Surg Oncol. 2022;29:5722-5729.
    PubMed     Abstract available


  118. FASANO G, Bayard S, Tamimi R, An A, et al
    Postmastectomy Breast Reconstruction Patterns at an Urban Academic Hospital and the Impact of Surgeon Gender.
    Ann Surg Oncol. 2022;29:5437-5444.
    PubMed     Abstract available


  119. KELLY BN, Liao EC, Specht MC
    ASO Author Reflections: Reducing Length of Stay and Postoperative Opioid Administration in a Same-Day Approach to Breast Reconstruction.
    Ann Surg Oncol. 2022;29:5720.
    PubMed    


  120. SPECHT MC, Kelly BN, Tomczyk E, Ford OA, et al
    One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol.
    Ann Surg Oncol. 2022;29:5711-5719.
    PubMed     Abstract available


  121. LUDWIG K, Wexelman B, Chen S, Cheng G, et al
    Home Recovery After Mastectomy: Review of Literature and Strategies for Implementation American Society of Breast Surgeons Working Group.
    Ann Surg Oncol. 2022;29:5799-5808.
    PubMed     Abstract available


  122. LUDWIG KK, Rao R
    ASO Author Reflections: Homing in on Safety-Home Recovery After Mastectomy.
    Ann Surg Oncol. 2022;29:5809-5810.
    PubMed    


    August 2022
  123. KAPP KA, Cheng AL, Bruton CM, Ahmadiyeh N, et al
    Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital.
    Ann Surg Oncol. 2022 Aug 29. pii: 10.1245/s10434-022-12139.
    PubMed     Abstract available


  124. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
    ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
    Ann Surg Oncol. 2022 Aug 29. pii: 10.1245/s10434-022-12265.
    PubMed    


  125. FARLEY CR, Irwin S, Adesoye T, Sun SX, et al
    ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
    Ann Surg Oncol. 2022 Aug 27. pii: 10.1245/s10434-022-12337.
    PubMed    


  126. KUERER HM
    Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2022 Aug 24. pii: 10.1245/s10434-022-12455.
    PubMed    


  127. CHICHURA A, Attai DJ, Kuchta K, Nicholson K, et al
    ASO Visual Abstract: Male Breast Cancer Patients and Surgeon Experience: The Male WhySurg Study.
    Ann Surg Oncol. 2022 Aug 24. pii: 10.1245/s10434-022-12218.
    PubMed    


  128. KLIMBERG VS
    ASO Video Abstract: Keynote Address at the ASBrS 2022 Annual Meeting. Low-Risk Breast Cancer-When Is Local Therapy Enough?
    Ann Surg Oncol. 2022 Aug 22. pii: 10.1245/s10434-022-12205.
    PubMed    


  129. FLANAGAN MR, Doody DR, Voutsinas J, Wu Q, et al
    ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12411.
    PubMed    


  130. ELDER EA, Livasy CA, Donahue EE, Neelands B, et al
    Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12300.
    PubMed     Abstract available


  131. WILLIAMS AD, Mamtani A
    ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy.
    Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12333.
    PubMed    


  132. SHAO Y, Yu Y, Luo Z, Guan H, et al
    ASO Visual Abstract: Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting-A Retrospective Analysis.
    Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12420.
    PubMed    


  133. HUYNH V, Vemuru S, Hampanda K, Pettigrew J, et al
    ASO Visual Abstract: No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12209.
    PubMed    


  134. UHLMANN RA, Mott SL, Curry M, Phadke S, et al
    ASO Visual Abstract: Analysis of Breast Cancer Patients' Understanding and Worry About Lymphedema.
    Ann Surg Oncol. 2022 Aug 12. pii: 10.1245/s10434-022-12244.
    PubMed    


  135. MONTAGNA G, Lee MK, Sevilimedu V, Barrio AV, et al
    ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022 Aug 12. pii: 10.1245/s10434-022-12326.
    PubMed    


  136. SWAMI N, Nguyen T, Dee EC, Franco I, et al
    Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups.
    Ann Surg Oncol. 2022 Aug 11. pii: 10.1245/s10434-022-12302.
    PubMed     Abstract available


  137. PEIFER HG, Raker C, Pesek S, Edmonson D, et al
    Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not.
    Ann Surg Oncol. 2022 Aug 11. pii: 10.1245/s10434-022-12196.
    PubMed     Abstract available


  138. OROZCO JIJ, Fancher CE, Grumley JG
    ASO Author Reflections: Breast-Conserving Therapy: A Safe Option in Young Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Aug 10. pii: 10.1245/s10434-022-12299.
    PubMed    


  139. PEIFER HG, Gass JS
    ASO Author Reflections: Breast-Specific Sensuality in the Sexually Inactive Breast Cancer Survivor.
    Ann Surg Oncol. 2022 Aug 9. pii: 10.1245/s10434-022-12341.
    PubMed    


  140. WILLIAMS AD, Barrio AV
    ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12324.
    PubMed    


  141. MITTENDORF EA, Kantor O, Weiss A, Richardson E, et al
    Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.
    Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12357.
    PubMed     Abstract available


  142. KENNARD K, Wang O, Ciocca R, Sabol J, et al
    ASO Author Reflection: Outcomes of Abbreviated MRI for Women of Any Breast Cancer Risk and Breast Density.
    Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12323.
    PubMed    


  143. DRAPALIK LM, Hue JJ, Simpson A, Freyvogel M, et al
    Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
    Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12237.
    PubMed     Abstract available


  144. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12320.
    PubMed    


  145. SHAO Y, Yu Y, Luo Z, Guan H, et al
    Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12369.
    PubMed     Abstract available


  146. SWAMI N, Nguyen T, Dee EC, Franco I, et al
    ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12375.
    PubMed    


  147. DRAPALIK LM, Amin AL, Miller ME
    ASO Author Reflections: Inflammatory Breast Cancer: The Exception to De-escalation of Care for Older Women?
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12338.
    PubMed    


  148. LI C, Lu N, He Z, Tan Y, et al
    ASO Visual Abstract: A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12078.
    PubMed    


  149. FISHER CS
    Neoadjuvant Chemotherapy for Breast Cancer: The Ultimate "Spy".
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12153.
    PubMed    


  150. DRAPALIK LM, Hue JJ, Simpson A, Freyvogel M, et al
    ASO Visual Abstract: Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12318.
    PubMed    


  151. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
    ASO Visual Abstract: A Systematic Review and Meta-analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
    Ann Surg Oncol. 2022 Aug 3. pii: 10.1245/s10434-022-12325.
    PubMed    


  152. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
    ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12214.
    PubMed    


  153. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
    ASO Visual Abstract: Black Women Are Less Likely to Be Classified as High Risk for Breast Cancer Using Tyrer-Cuzick 8 Model.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12243.
    PubMed    


  154. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
    ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12246.
    PubMed    


  155. SHUBECK S, Sevilimedu V, Berger E, Robson M, et al
    Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy.
    Ann Surg Oncol. 2022;29:4706-4713.
    PubMed     Abstract available


  156. NELSON JA, Allen RJ Jr
    ASO Author Reflections: Deeper Understanding of Patient-Reported Outcomes in Breast Reconstruction Patients Not Requiring Radiation Therapy: Harnessing Propensity Matching Methodology.
    Ann Surg Oncol. 2022;29:5276-5277.
    PubMed    


  157. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden.
    Ann Surg Oncol. 2022;29:4750-4751.
    PubMed    


  158. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
    The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA).
    Ann Surg Oncol. 2022;29:4777-4786.
    PubMed     Abstract available


  159. DINOME ML, Marzese DM
    ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.
    Ann Surg Oncol. 2022;29:4725-4726.
    PubMed    


  160. NELSON JA, Chu JJ, McCarthy CM, Stern CS, et al
    BREAST-Q REACT: Clinical Reference Values for the BREAST-Q in Post-mastectomy Breast Reconstruction Patients.
    Ann Surg Oncol. 2022;29:5280-5293.
    PubMed     Abstract available


  161. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
    ASO Author Reflections: SAMBA's Practice Advisory for the Use of Pectoralis Blocks in Breast Surgery: Overview and Lingering Questions.
    Ann Surg Oncol. 2022;29:4787-4788.
    PubMed    


  162. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
    Matched Preliminary Analysis of Patient-Reported Outcomes following Autologous and Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2022;29:5266-5275.
    PubMed     Abstract available


  163. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
    A Matched Preliminary Analysis of Patient-Reported Outcomes After Autologous and Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2022;29:5278-5279.
    PubMed    


  164. CHU JJ, Nelson JA
    ASO Author Reflections: Patient-Reported Outcomes for Breast Reconstruction Clinical Practice.
    Ann Surg Oncol. 2022;29:5294-5295.
    PubMed    


  165. HUYNH V, Vemuru S, Hampanda K, Pettigrew J, et al
    No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12126.
    PubMed     Abstract available


  166. CO LMB, Dee EC, Eala MAB, Ang SD, et al
    Access to Surgical Treatment for Breast Cancer in the Philippines.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12311.
    PubMed     Abstract available


  167. UHLMANN RA, Mott SL, Curry M, Phadke S, et al
    Analysis of the Understanding and Worry about Lymphedema of Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12189.
    PubMed     Abstract available


  168. BAYARD S, Bea VJ
    Disparities in Time to Treatment for Breast Cancer: Shifting Focus to the Root Cause.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-11948.
    PubMed    


    July 2022
  169. KLIMBERG VS
    Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?
    Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12125.
    PubMed     Abstract available


  170. NAKHLIS F
    ASO Visual Abstract: Inflammatory Breast Cancer-Is There a Role for De-escalation of Surgery?
    Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12217.
    PubMed    


  171. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
    ASO Visual Abstract: Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12183.
    PubMed    


  172. PEIFER HG, Raker C, Pesek S, Edmonson D, et al
    ASO Visual Abstract: Breast-Specific Sensuality in Breast Cancer Survivors - Sexually Active or Not.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12249.
    PubMed    


  173. TASOULIS MK, Karakatsanis A
    ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12310.
    PubMed    


  174. KANTOR O, Burstein HJ, King TA, Shak S, et al
    ASO Visual Abstract: Expanding Staging Criteria in T1-2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx.
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12294.
    PubMed    


  175. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
    ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly-Are We Accomplishing Our Treatment Goals?
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12282.
    PubMed    


  176. BAYARD S, Bea VJ
    ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-11981.
    PubMed    


  177. MONTAGNA G, Lee MK, Sevilimedu V, Barrio AV, et al
    Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12240.
    PubMed     Abstract available


  178. KANTOR O, Burstein HJ, King TA, Shak S, et al
    Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12225.
    PubMed     Abstract available


  179. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
    ASO Visual Abstract: Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer Undergoing Upfront Surgery.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12279.
    PubMed    


  180. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
    Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12190.
    PubMed     Abstract available


  181. CHICHURA A, Attai DJ, Kuchta K, Nicholson K, et al
    Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12135.
    PubMed     Abstract available


  182. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
    ASO Visual Abstract: Outcomes of Abbreviated MRI (Ab-MRI) for Women of Any Breast Cancer Risk and Breast Density in a Community Academic Setting.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12247.
    PubMed    


  183. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
    Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12191.
    PubMed     Abstract available


  184. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
    ASO Visual Abstract: Factors Influencing Non-Sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12270.
    PubMed    


  185. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
    PubMed     Abstract available


  186. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
    Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?
    Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12206.
    PubMed     Abstract available


  187. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
    ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
    Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12278.
    PubMed    


  188. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
    ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
    Ann Surg Oncol. 2022 Jul 21. pii: 10.1245/s10434-022-12272.
    PubMed    


  189. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
    Outcomes of Abbreviated MRI (Ab-MRI) for Women of any Breast Cancer Risk and Breast Density in a Community Academic Setting.
    Ann Surg Oncol. 2022 Jul 20. pii: 10.1245/s10434-022-12194.
    PubMed     Abstract available


  190. FARLEY CR, Irwin S, Adesoye T, Sun SX, et al
    Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
    Ann Surg Oncol. 2022 Jul 19. pii: 10.1245/s10434-022-12142.
    PubMed     Abstract available


  191. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
    A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12197.
    PubMed     Abstract available


  192. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
    Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery-A Rare Complication and a Proposed Management Strategy from the British and Italian Experience.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12094.
    PubMed     Abstract available


  193. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
    How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12193.
    PubMed     Abstract available


  194. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
    Stage IV Non-breast Cancer Patients and Screening Mammography: It is Time to Stop.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12132.
    PubMed     Abstract available


  195. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
    ASO Visual Abstract: Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12245.
    PubMed    


  196. COBB AN, Sun SX
    ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12235.
    PubMed    


  197. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
    Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12143.
    PubMed     Abstract available


  198. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
    ASO Visual Abstract: Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12163.
    PubMed    


  199. NAKHLIS F
    Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
    Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12138.
    PubMed     Abstract available


  200. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12010.
    PubMed    


  201. COBB AN, Diao K, Teshome M, Lucci A, et al
    Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
    Ann Surg Oncol. 2022 Jul 14. pii: 10.1245/s10434-022-12144.
    PubMed     Abstract available


  202. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
    Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12064.
    PubMed     Abstract available


  203. AMLICKE MJ, Spanheimer PM
    ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12175.
    PubMed    


  204. LAWS A, Pastorello R, Dey T, Grossmith S, et al
    ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12165.
    PubMed    


  205. FLANAGAN MR, Sharifi N, Gadi VK
    ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer.
    Ann Surg Oncol. 2022 Jul 11. pii: 10.1245/s10434-022-12091.
    PubMed    


  206. GUTNIK LA, Fish LJ, Gallagher J, Greenup RA, et al
    'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12160.
    PubMed    


  207. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
    ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12081.
    PubMed    


  208. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
    ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12122.
    PubMed    


  209. LAWS A, Pastorello R, Dey T, Grossmith S, et al
    Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12054.
    PubMed     Abstract available


  210. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
    The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12065.
    PubMed     Abstract available


  211. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
    ASO Visual Abstract: Incidence of Occult Breast Cancer in Carriers of BRCA1/2 and Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy-When is Sentinel Lymph Node Biopsy Indicated?
    Ann Surg Oncol. 2022 Jul 8. pii: 10.1245/s10434-022-12011.
    PubMed    


  212. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
    ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
    Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12120.
    PubMed    


  213. HIEKEN TJ, Hoskin TL
    ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
    Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12181.
    PubMed    


  214. COOPEY SB
    Supraclavicular and Contralateral Axillary Lymph Node Involvement in Breast Cancer Patients.
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12134.
    PubMed     Abstract available


  215. PILTIN MA, Boughey JC
    ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer?
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12169.
    PubMed    


  216. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
    Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12140.
    PubMed     Abstract available


  217. MARTINEZ EO, Jorns JM, Kong AL, Cortina CS, et al
    ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12137.
    PubMed    


  218. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
    ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays.
    Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12069.
    PubMed    


  219. BOUGHEY JC, Hoskin TL, Goetz MP
    ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer-Effects of Age and Tumor Ki67.
    Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12004.
    PubMed    


  220. FLANAGAN MR, Doody DR, Voutsinas J, Wu Q, et al
    Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12088.
    PubMed     Abstract available


    June 2022
  221. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
    Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12066.
    PubMed     Abstract available


  222. HIEKEN TJ, Boughey JC, Degnim AC, Glazebrook KN, et al
    Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12037.
    PubMed    


  223. LI C, Lu N, He Z, Tan Y, et al
    A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12034.
    PubMed     Abstract available


  224. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
    Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12032.
    PubMed     Abstract available


  225. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
    Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2022 Jun 25. pii: 10.1245/s10434-022-12056.
    PubMed     Abstract available


  226. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
    Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
    Ann Surg Oncol. 2022 Jun 24. pii: 10.1245/s10434-022-12001.
    PubMed     Abstract available


  227. KUS T, Aktas G
    Correction to : Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
    Ann Surg Oncol. 2022 Jun 22. pii: 10.1245/s10434-022-12072.
    PubMed    


  228. MCGUIRE KP, Arthur DW, Mamounas EP
    Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-12048.
    PubMed    


  229. HUANG X, Luo Z, Fu DY
    ASO Author Reflections: Simplified Nomogram Predictive of Survival for Young Breast Cancer Patients.
    Ann Surg Oncol. 2022 Jun 17. pii: 10.1245/s10434-022-11966.
    PubMed    


  230. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2022 Jun 16. pii: 10.1245/s10434-022-11958.
    PubMed     Abstract available


  231. CHEN JC, Bazan JG, Obeng-Gyasi S
    ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12016.
    PubMed    


  232. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
    ASO Visual Abstract: Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting 1-2 Metastatic Sentinel Lymph Nodes: The Multicenter Randomized Clinical Trial SINODAR-ONE.
    Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11908.
    PubMed    


  233. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
    Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11975.
    PubMed     Abstract available


  234. KHAN SA, Schuetz S, Hosseini O
    Correction to: Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
    Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11995.
    PubMed    


  235. CROWN A, Muhsen S, Sevilimedu V, Kelvin J, et al
    Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
    Ann Surg Oncol. 2022 Jun 7. pii: 10.1245/s10434-022-11910.
    PubMed     Abstract available


  236. EISENBERG ER, Weiss A, Prakash I, Skamene S, et al
    Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort.
    Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11947.
    PubMed     Abstract available


  237. HUANG X, Luo Z, Liang W, Xie G, et al
    ASO Visual Abstract: Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2022 Jun 5. pii: 10.1245/s10434-022-11968.
    PubMed    


  238. KUS T, Aktas G
    Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
    Ann Surg Oncol. 2022 Jun 4. pii: 10.1245/s10434-022-11979.
    PubMed     Abstract available


  239. HUANG X, Luo Z, Liang W, Xie G, et al
    Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11911.
    PubMed     Abstract available


  240. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    ASO Visual Abstract: Additional Work-Ups Recommended During Preoperative Breast MRI, Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3851-3852.
    PubMed    


  241. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    ASO Visual Abstract: Mastectomy or Margin Reexcision? A Nomogram for Close/Positive Margins after Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3749.
    PubMed    


  242. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Visual Abstract: Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3838.
    PubMed    


  243. WEISS A, King C, Grossmith S, Portnow L, et al
    ASO Visual Abstract: How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective Consecutive Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3774-3775.
    PubMed    


  244. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3829-3835.
    PubMed     Abstract available


  245. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
    Ann Surg Oncol. 2022;29:3836-3837.
    PubMed    


  246. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    Additional Workups Recommended During Preoperative Breast MRI: Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3839-3848.
    PubMed     Abstract available


  247. MAIMONE S, McLaughlin SA
    ASO Author Reflections: Optimizing Additional Workups from Preoperative Breast MRI.
    Ann Surg Oncol. 2022;29:3849-3850.
    PubMed    


  248. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    ASO Visual Abstract: Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3799.
    PubMed    


  249. LIANG DH, Black D, Yi M, Luo CK, et al
    Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
    Ann Surg Oncol. 2022;29:3822-3828.
    PubMed     Abstract available


  250. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
    Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
    Ann Surg Oncol. 2022;29:3578-3590.
    PubMed     Abstract available


  251. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    ASO Visual Abstract: Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3739.
    PubMed    


  252. REDFERN RE, Shermis RB
    ASO Visual Abstract: Initial Experience Using Magseed for Breast Lesion Localization Compared to Wire-Guided Localization-Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3784.
    PubMed    


  253. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3785-3797.
    PubMed     Abstract available


  254. REDFERN RE, Shermis RB
    Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3776-3783.
    PubMed     Abstract available


  255. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3726-3736.
    PubMed     Abstract available


  256. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3740-3748.
    PubMed     Abstract available


  257. WEISS A, King C, Grossmith S, Portnow L, et al
    How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3764-3771.
    PubMed     Abstract available


  258. KOPKASH K, Novak K, Murphy R, Deliere A, et al
    ASO Visual Abstract: Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and an Operating Room Positioning Protocol.
    Ann Surg Oncol. 2022;29:3863.
    PubMed    


  259. CORTINA CS, Kong AL
    ASO Author Reflections: The Evolving Multidisciplinary Management of the Axilla in Mastectomy Patients.
    Ann Surg Oncol. 2022;29:3853-3854.
    PubMed    


  260. JU T, Momeni A, Wapnir I
    ASO Author Reflections: Preventing Nipple Loss by Surgical Delay in Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2022;29:3855-3856.
    PubMed    


    May 2022
  261. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.
    Ann Surg Oncol. 2022 May 29. pii: 10.1245/s10434-022-11960.
    PubMed    


  262. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
    Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
    Ann Surg Oncol. 2022 May 26. pii: 10.1245/s10434-022-11916.
    PubMed     Abstract available


  263. KHAN SA, Schuetz S, Husseini O
    Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
    Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11900.
    PubMed     Abstract available


  264. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
    Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
    Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11834.
    PubMed     Abstract available


  265. RELATION T, Bhattacharyya O, Oppong BA
    ASO Author Reflections: Surgery Refusal in Breast Cancer Has a Disproportionate Impact on Black and Hispanic Women.
    Ann Surg Oncol. 2022 May 17. pii: 10.1245/s10434-022-11906.
    PubMed    


  266. BOUGHEY JC, Blair SL, Subhedar PD, Edge SB, et al
    The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer.
    Ann Surg Oncol. 2022 May 16. pii: 10.1245/s10434-022-11899.
    PubMed    


  267. BOUGHEY JC, Hoskin TL, Goetz MP
    Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11871.
    PubMed     Abstract available


  268. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
    Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11866.
    PubMed     Abstract available


  269. HUGHES KS, Yin K
    A Woman Needs to Know She Is a BRCA Carrier Before She Develops Breast Cancer.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11860.
    PubMed    


  270. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
    ASO Visual Abstract: Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11877.
    PubMed    


  271. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    ASO Visual Abstract: Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: An Alternative to Sentinel-Node-Biopsy?
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11876.
    PubMed    


  272. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
    ASO Visual Abstract: Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11743.
    PubMed    


  273. RELATION T, Ndumele A, Bhattacharyya O, Fisher JL, et al
    Surgery Refusal Among Black and Hispanic Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11832.
    PubMed     Abstract available


  274. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
    ASO Visual Abstract: Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women With Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
    Ann Surg Oncol. 2022 May 2. pii: 10.1245/s10434-022-11795.
    PubMed    


  275. VERBUS EA, Khan TM, Hernandez JM, Kulkarni S, et al
    Evaluating the Effects of a Tissue Selective Estrogen Complex (TSEC) in Women with Newly Diagnosed Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:2769-2770.
    PubMed    


    April 2022
  276. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
    Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11829.
    PubMed     Abstract available


  277. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria.
    Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11845.
    PubMed    


  278. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    ASO Visual Abstract: Contemporary Axillary Management in cT1-2N0 Breast Cancer with 1-2 Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11818.
    PubMed    


  279. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
    ASO Visual Abstract: Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
    Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11608.
    PubMed    


  280. KARZAI S, Port E, Siderides C, Valente C, et al
    ASO Visual Abstract: Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2022 Apr 27. pii: 10.1245/s10434-022-11636.
    PubMed    


  281. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
    ASO Visual Abstract: Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality: Delay, Facilities, and Breast Cancer Mortality.
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11794.
    PubMed    


  282. SONG JH, Kantor O, Mittendorf EA, King TA, et al
    ASO Visual Abstract: Race and Site of Care Impact Treatment Delays for Older Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11593.
    PubMed    


  283. ADESOYE T, Sun SX, Schaverien MV, Woodward WA, et al
    Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11788.
    PubMed    


  284. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
    Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
    Ann Surg Oncol. 2022 Apr 24. pii: 10.1245/s10434-022-11728.
    PubMed     Abstract available


  285. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11759.
    PubMed     Abstract available


  286. MATAR R, Morrow M
    ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence.
    Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11769.
    PubMed    


  287. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
    ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 19. pii: 10.1245/s10434-022-11711.
    PubMed    


  288. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
    Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality.
    Ann Surg Oncol. 2022 Apr 18. pii: 10.1245/s10434-022-11720.
    PubMed     Abstract available


  289. SCHWARTZ T
    Personal Systemic Therapy Decision-Making has Officially Arrived for Node-Positive Breast Cancer.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11689.
    PubMed    


  290. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
    ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11744.
    PubMed    


  291. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
    ASO Visual Abstract: Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11778.
    PubMed    


  292. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
    Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11684.
    PubMed     Abstract available


  293. HUANG CC, Tseng LM
    ASO Author Reflections: Broaden the Targeted Population of Synthetic Lethality for Taiwanese Breast Cancer.
    Ann Surg Oncol. 2022 Apr 7. pii: 10.1245/s10434-022-11407.
    PubMed     Abstract available


  294. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
    Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11677.
    PubMed     Abstract available


  295. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
    ASO Visual Abstract: The Role of Safety Net Hospitals in Reducing Disparities in Breast Cancer Care.
    Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11694.
    PubMed    


  296. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
    Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
    Ann Surg Oncol. 2022 Apr 5. pii: 10.1245/s10434-022-11631.
    PubMed     Abstract available


  297. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
    Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 4. pii: 10.1245/s10434-022-11666.
    PubMed     Abstract available


  298. GUI Y, Chen Q, Li S, Yang X, et al
    ASO Visual Abstract: Safety and feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer-A Single-Center Retrospective Study.
    Ann Surg Oncol. 2022 Apr 3. pii: 10.1245/s10434-022-11449.
    PubMed    


  299. LE BLANC J, Golshan M, Lannin D, Greenup R, et al
    Association of Medicaid Expansion with Post-mastectomy Reconstruction Rates.
    Ann Surg Oncol. 2022;29:2181-2189.
    PubMed     Abstract available


  300. REGIS C, Le Deley MC, Bogart E, Leguillette C, et al
    Functional Cerebral MRI Evaluation of Integration of Breast Reconstruction into the Body Schema.
    Ann Surg Oncol. 2022;29:2652-2661.
    PubMed     Abstract available


  301. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
    Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
    Ann Surg Oncol. 2022;29:2193-2199.
    PubMed     Abstract available


  302. KARZAI S, Port E, Siderides C, Valente C, et al
    Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2022 Apr 1. pii: 10.1245/s10434-022-11581.
    PubMed     Abstract available


  303. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
    ASO Visual Abstract: Upstaging of Fibroepithelial Lesions-A Single-Institution Experience.
    Ann Surg Oncol. 2022;29:2201.
    PubMed    


  304. LE BLANC J, Park T, Lannin D
    ASO Author Reflections: Despite Medicaid Expansion, Large Disparities in Breast Reconstruction Persist.
    Ann Surg Oncol. 2022;29:2190.
    PubMed    


    March 2022
  305. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
    The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care.
    Ann Surg Oncol. 2022 Mar 31. pii: 10.1245/s10434-022-11576.
    PubMed     Abstract available


  306. CROWN A, Joseph KA
    ASO Author Reflections: Reinforcing the Safety Net: Supporting Safety-Net Hospitals in Mitigating Breast Cancer Disparities.
    Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11640.
    PubMed    


  307. SONG JH, Kantor O, Mittendorf EA, King TA, et al
    Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11543.
    PubMed     Abstract available


  308. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
    Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
    Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11545.
    PubMed     Abstract available


  309. FRIEDMAN-ELDAR O, Ozmen T, El Haddi SJ, Goel N, et al
    Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes.
    Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11473.
    PubMed     Abstract available


  310. FRIEDMAN-ELDAR O, Ozmen T, Haddi SJE, Goel N, et al
    ASO Visual Abstract: Axillary Response to Neoadjuvant Therapy in Node-Positive ER+/HER2- Breast Cancer Patients-Predictors and Oncologic Outcomes.
    Ann Surg Oncol. 2022 Mar 14. pii: 10.1245/s10434-022-11531.
    PubMed    


  311. RING A, Campo D, Porras TB, Kaur P, et al
    Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Mar 8. pii: 10.1245/s10434-022-11589.
    PubMed    


  312. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
    The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Mar 5. pii: 10.1245/s10434-022-11367.
    PubMed     Abstract available


  313. JIWA N, Kumar S, Gandhewar R, Chauhan H, et al
    Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:1774-1786.
    PubMed     Abstract available


  314. VICINI E, Leonardi MC, Fontana SKR, Pagan E, et al
    How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes.
    Ann Surg Oncol. 2022;29:1750-1760.
    PubMed     Abstract available


  315. ESGUEVA AJ, Noordhoek I, Kranenbarg EM, Espinosa-Bravo M, et al
    Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry.
    Ann Surg Oncol. 2022;29:1722-1734.
    PubMed     Abstract available


  316. MATAR R, Sevilimedu V, Park A, King TA, et al
    Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation.
    Ann Surg Oncol. 2022;29:1670-1679.
    PubMed     Abstract available


  317. WILLIAMS AD, Chang C, Sigurdson ER, Wang CH, et al
    Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic.
    Ann Surg Oncol. 2022;29:1683-1691.
    PubMed     Abstract available


  318. WANG W, Shen Z, Zhang J, Chen H, et al
    A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Ann Surg Oncol. 2022;29:1533-1539.
    PubMed     Abstract available


  319. LAWS A, Katlin F, Nakhlis F, Chikarmane SA, et al
    Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision.
    Ann Surg Oncol. 2022;29:1660-1667.
    PubMed     Abstract available


  320. SOEGAARD BALLESTER JM, Goodsell KE, Ermer JP, Karakousis GC, et al
    New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation.
    Ann Surg Oncol. 2022;29:1797-1804.
    PubMed     Abstract available


  321. JIWA N, Leff D
    ASO Authors Reflection: Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:1787-1788.
    PubMed    


  322. VICINI E, Fontana SKR, Leonardi MC, Veronesi P, et al
    ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
    Ann Surg Oncol. 2022;29:1761-1762.
    PubMed    


  323. PAWLOSKI KR, Moo TA
    ASO Author Reflection: Pain Control Can Be Optimized with Surgeon-Administered Local Anesthesia in Patients Undergoing Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia.
    Ann Surg Oncol. 2022;29:1746-1747.
    PubMed    


  324. MATAR R, Pilewskie M
    ASO Author Reflections: Observation After a Core Biopsy Diagnosis of Classic-Type LCIS Is a Safe Standard of Practice.
    Ann Surg Oncol. 2022;29:1680-1681.
    PubMed    


  325. WANG W, Shen B
    ASO Author Reflections: Lymphadenectomy in Distal Pancreatectomy for Ductal Adenocarcinoma: How to Do Better?
    Ann Surg Oncol. 2022;29:1540-1541.
    PubMed    


  326. ROSSI AJ, Verbus EA, Horst K, De Martini W, et al
    Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS).
    Ann Surg Oncol. 2022;29:1528-1529.
    PubMed    


    February 2022
  327. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
    ASO Visual Abstract: A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (Sln) Detection in Early Breast Cancer.
    Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-021-11313.
    PubMed    


  328. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
    ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Feb 20. pii: 10.1245/s10434-022-11425.
    PubMed    


  329. GUI Y, Chen Q, Chen L
    ASO Author Reflections: Minimally Invasive Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction for Early Breast Cancer.
    Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11422.
    PubMed    


  330. GUI Y, Chen Q, Li S, Yang X, et al
    Safety and Feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer: A Single-Center Retrospective Study.
    Ann Surg Oncol. 2022 Feb 16. pii: 10.1245/s10434-022-11420.
    PubMed     Abstract available


  331. CARMONA CA, Yee S, Seminsky M, Glass K, et al
    ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Feb 15. pii: 10.1245/s10434-022-11340.
    PubMed    


  332. COBB AN, Adesoye T, Teshome M
    Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer.
    Ann Surg Oncol. 2022 Feb 12. pii: 10.1245/s10434-022-11343.
    PubMed    


  333. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
    ASO Visual Abstract: Can We Successfully Deescalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma In Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Ann Surg Oncol. 2022 Feb 3. pii: 10.1245/s10434-021-11305.
    PubMed    


  334. BAE J, Jeon BJ, Mun GH, Bang SI, et al
    Predictors for Implant Rupture in Two-Stage Tissue Expander-Based Breast Reconstruction: A Retrospective Cohort Study.
    Ann Surg Oncol. 2022;29:1100-1108.
    PubMed     Abstract available


  335. MAMTANI A, Sevilimedu V, Vincent A, Morrow M, et al
    Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers.
    Ann Surg Oncol. 2022;29:1043-1048.
    PubMed     Abstract available


  336. KELLY BN, Faulkner HR, Smith BL, Korotkin JE, et al
    Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction?
    Ann Surg Oncol. 2022;29:1033-1040.
    PubMed     Abstract available


  337. ERDRICH J, Cordova-Marks F, Monetathchi AR, Wu M, et al
    Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women.
    Ann Surg Oncol. 2022;29:1019-1030.
    PubMed     Abstract available


  338. KANTOR O, Means J, Grossmith S, Dey T, et al
    Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022;29:972-980.
    PubMed     Abstract available


  339. SHAMMAS RL, Fish LJ, Sergesketter AR, Offodile AC 2nd, et al
    Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods Study.
    Ann Surg Oncol. 2022;29:1109-1119.
    PubMed     Abstract available


  340. ERDRICH J
    ASO Author Reflections: Mastectomy Versus Lumpectomy: Are There Surgical Disparities for Native American Women Compared with White Women?
    Ann Surg Oncol. 2022;29:1031-1032.
    PubMed    


  341. MAMTANI A, Morrow M
    ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision.
    Ann Surg Oncol. 2022;29:1049-1050.
    PubMed    


  342. MONTAGNA G, Weber WP, Geroldinger A, Fitzal F, et al
    ASO Author Reflections: Impact of Resection Volume on Risk of Local Recurrence-The OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2022;29:1071-1072.
    PubMed    


  343. SHAMMAS RL, Greenup RA, Hollenbeck ST
    ASO Author Reflections: Decision Support Tools Are Needed to Address Dissatisfaction Among Women Seeking Post-Mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2022;29:1120-1121.
    PubMed    


    January 2022
  344. KHAN SY, Melkus MW, Rasha F, Castro M, et al
    Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11157.
    PubMed     Abstract available


  345. MATHEW AT, Jain B, Dee EC, Johnson J, et al
    Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-022-11349.
    PubMed    


  346. KHAN SY, Melkus MW, Rasha F, Castro M, et al
    ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study.
    Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11240.
    PubMed    


  347. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
    ASO Visual Abstract: Surgical Management of the Axilla of Triple-Negative Breast Cancer in the Z1071 Era-A Propensity-Score Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11281.
    PubMed    


  348. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
    ASO Visual Abstract: Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Ann Surg Oncol. 2022 Jan 21. pii: 10.1245/s10434-021-11178.
    PubMed    


  349. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes KE, et al
    Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
    Ann Surg Oncol. 2022 Jan 17. pii: 10.1245/s10434-021-11260.
    PubMed     Abstract available


  350. GUAY E, Cordeiro E, Roberts A
    ASO Visual Abstract: Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11246.
    PubMed    


  351. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
    ASO Visual Abstract: Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed-Methods Study.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11256.
    PubMed    


  352. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
    ASO Visual Abstract: The Breast Cancer Patient Experience of Telemedicine During COVID-19.
    Ann Surg Oncol. 2022 Jan 14. pii: 10.1245/s10434-021-11183.
    PubMed    


  353. LIN SQ, Vo NP, Yen YC, Tam KW, et al
    ASO Visual Abstract: Outcomes of Sentinel Node Biopsy in Women with Breast Cancer Following Neoadjuvant Therapy-Systematic Review and Meta-Analysis of Real-World Data.
    Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11306.
    PubMed    


  354. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes K, et al
    ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
    Ann Surg Oncol. 2022 Jan 12. pii: 10.1245/s10434-021-11312.
    PubMed    


  355. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
    ASO Visual Abstract: Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11272.
    PubMed    


  356. LIN SQ, Vo NP, Yen YC, Tam KW, et al
    Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11297.
    PubMed     Abstract available


  357. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
    Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022 Jan 10. pii: 10.1245/s10434-021-11194.
    PubMed     Abstract available


  358. CARMONA CA, Yee S, Seminsky M, Glass K, et al
    Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11254.
    PubMed     Abstract available


  359. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
    ASO Visual Abstract: Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11172.
    PubMed    


  360. RING A, Campo D, Porras TB, Kaur P, et al
    Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11135.
    PubMed     Abstract available


  361. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
    A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.
    Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11255.
    PubMed     Abstract available


  362. KONISHI T, Fujiogi M, Tanabe M, Seto Y, et al
    ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11277.
    PubMed    


  363. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
    Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11212.
    PubMed     Abstract available


  364. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
    ASO Visual Abstract: Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11130.
    PubMed    


  365. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
    Can We Successfully De-Escalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11140.
    PubMed     Abstract available


  366. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
    ASO Visual Abstract: Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-10971.
    PubMed    


  367. TAMIRISA N, Hunt KK
    Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11223.
    PubMed    


  368. CARMONA C, Warner E
    ASO Author Reflections: Referring Young Breast Cancer Patients for Fertility Preservation: Significant Progress but Still Room for Improvement.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11288.
    PubMed    


  369. PLICHTA JK
    Circulating Tumor Cells and Breast Cancer: The Long and Winding Road Behind and Before Us.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11301.
    PubMed    


  370. RING A, Campo D, Porras TB, Kaur P, et al
    ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11216.
    PubMed    


  371. CORDEIRO E, Guay E, Roberts A
    ASO Author Reflections: Improving Efficiency of Care for Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11164.
    PubMed    


  372. DIETZ JR
    Editorial: Impact of the Covid-19 Pandemic on Breast Cancer Treatment and Patient Experience.
    Ann Surg Oncol. 2022 Jan 2. pii: 10.1245/s10434-021-11227.
    PubMed    


  373. DE LORENZI F, Borelli F, Pagan E, Bagnardi V, et al
    Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis.
    Ann Surg Oncol. 2022;29:427-436.
    PubMed     Abstract available


  374. GANESH KUMAR N, Berlin NL, Hawley ST, Jagsi R, et al
    Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy.
    Ann Surg Oncol. 2022;29:535-544.
    PubMed     Abstract available


  375. GURAM S, Covelli AM, O'Neill AC, Shultz DB, et al
    Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment.
    Ann Surg Oncol. 2022;29:522-532.
    PubMed     Abstract available


  376. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
    Phyllodes Tumors: A Scoping Review of the Literature.
    Ann Surg Oncol. 2022;29:446-459.
    PubMed     Abstract available


  377. SAHAKYAN MA, Verbeke CS, Tholfsen T, Ignjatovic D, et al
    Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2022;29:366-375.
    PubMed     Abstract available


  378. DE LORENZI F, Borelli F
    ASO Author Reflections: The Safety of Oncoplastic Surgery for Multicentric and Multifocal Breast Tumors.
    Ann Surg Oncol. 2022;29:437.
    PubMed    


  379. MATROS E, Offodile AC 2nd
    Financial Toxicity Following Post-Mastectomy Reconstruction: Consideration for a Novel Outcome Measure.
    Ann Surg Oncol. 2022;29:25-27.
    PubMed    


  380. GANESH KUMAR N, Momoh AO
    ASO Author Reflections: Characterizing Financial Toxicity in Post-mastectomy Breast Reconstruction: A Need for Additional Perspectives.
    Ann Surg Oncol. 2022;29:545-546.
    PubMed    


  381. SUN SX, Suk R, Kuerer HM, Cantor SB, et al
    No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:39-41.
    PubMed    


  382. COVELLI AM, Gladdy RA
    ASO Author Reflections: Rethinking Radiation Associated Angiosarcoma of the Breast-Secondary Malignancies That Require Expert Care for Improved Outcomes.
    Ann Surg Oncol. 2022;29:533-534.
    PubMed    


  383. SAHAKYAN MA, Labori KJ, Edwin B
    ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?
    Ann Surg Oncol. 2022;29:376-377.
    PubMed    


    December 2021
  384. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
    Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed Methods Study.
    Ann Surg Oncol. 2021 Dec 20. pii: 10.1245/s10434-021-11209.
    PubMed     Abstract available


  385. KING CA, Bartholomew AJ, Sosin M, Avila A, et al
    A Critical Appraisal of Late Complications of Prepectoral versus Subpectoral Breast Reconstruction Following Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2021;28:9150-9158.
    PubMed     Abstract available


  386. ZHANG X, Liu W, Hai T, Li F, et al
    Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
    Ann Surg Oncol. 2021;28:8643-8650.
    PubMed     Abstract available


  387. MURPHY BM, Hoskin TL, Degnim AC, Boughey JC, et al
    Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.
    Ann Surg Oncol. 2021;28:8729-8739.
    PubMed     Abstract available


  388. JAMES TA, Fan B
    ASO Author Reflections: National Analysis of Breast Surgery Malpractice Cases: A Teachable Moment?
    Ann Surg Oncol. 2021;28:8116-8117.
    PubMed    


  389. LEE SE, Kim HY, Yoon JH, Kim EK, et al
    Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.
    Ann Surg Oncol. 2021;28:8699-8709.
    PubMed     Abstract available


  390. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
    Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor?
    Ann Surg Oncol. 2021;28:8679-8687.
    PubMed     Abstract available


  391. FAN B, Pardo J, Yu-Moe CW, Janes M, et al
    Malpractice Cases in Breast Surgery: An Assessment of Litigation Involving Surgeons.
    Ann Surg Oncol. 2021;28:8109-8115.
    PubMed     Abstract available


  392. RING A, Lang JE
    ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer.
    Ann Surg Oncol. 2021 Dec 1. pii: 10.1245/s10434-021-11139.
    PubMed    


  393. ZHANG X, Liu W, Hai T, Li F, et al
    ASO Visual Abstract: Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-analysis.
    Ann Surg Oncol. 2021;28.
    PubMed     Abstract available


  394. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
    ASO Visual Abstract: Phyllodes Tumors: A Scoping Review of the Literature.
    Ann Surg Oncol. 2021;28.
    PubMed    


  395. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
    ASO Visual Abstract: Choosing Between Mastectomy and Breast-Conserving Therapy-Is Patient Distress an Influencing Factor?
    Ann Surg Oncol. 2021;28.
    PubMed    


  396. STAHL K, Wong W, Dodge D, Brooks A, et al
    ASO Visual Abstract: Benefits of Surgical Treatment in Stage IV Breast Cancer in Patients with Known Hormone Receptor and HER2 Status.
    Ann Surg Oncol. 2021;28.
    PubMed    


  397. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
    ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
    Ann Surg Oncol. 2021;28.
    PubMed    


  398. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    ASO Visual Abstract: Surgical decision-making surrounding contralateral prophylactic mastectomy-- Comparison of treatment goals, preferences, and psychosocial outcomes from a multi-center survey of breast cancer patients.
    Ann Surg Oncol. 2021;28.
    PubMed     Abstract available


  399. PAWLOSKI KR, El-Tamer M
    Reply to Significance of 21-Gene Nonconcordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
    Ann Surg Oncol. 2021;28.
    PubMed    


  400. SORSCHER S
    Significance of 21-Gene Non-Concordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
    Ann Surg Oncol. 2021;28.
    PubMed    


  401. ALTUNDAG K
    Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast.
    Ann Surg Oncol. 2021;28.
    PubMed    


  402. MCCORMICK PJ, Assel M, Van Zee KJ, Vickers AJ, et al
    Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"
    Ann Surg Oncol. 2021;28.
    PubMed    


  403. LI L, Zhao X, Xiang B, Tang X, et al
    Ketorolac following Mastectomy: Is There an Increased Risk of Reoperation?
    Ann Surg Oncol. 2021;28.
    PubMed    


  404. GIULIANO AE, Vane M
    Reply to Comment on: "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
    Ann Surg Oncol. 2021;28.
    PubMed    


  405. CORTINA CS, Kong AL
    Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
    Ann Surg Oncol. 2021;28.
    PubMed    


  406. JAMES TA, Zhang JQ
    ASO Author Reflections: Addressing the Early Onset of Clinical Practice Distress in Breast Surgery.
    Ann Surg Oncol. 2021;28.
    PubMed    


  407. CORSO G
    Second Reply to: "Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?"
    Ann Surg Oncol. 2021;28.
    PubMed    


    November 2021
  408. TONNESON JE, Boughey JC
    ASO Author Reflections: How COVID-19 Impacted Breast Cancer Presentation and Management.
    Ann Surg Oncol. 2021 Nov 30. pii: 10.1245/s10434-021-11098.
    PubMed    


  409. OBENG-GYASI S, Rose J, Koroukian S
    ASO Author Reflections: Medicaid Expansion is Key in Mitigating Surgical Disparities in Low-Income Breast Cancer Patients.
    Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11138.
    PubMed    


  410. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
    Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
    Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11137.
    PubMed     Abstract available


  411. GUAY E, Cordeiro E, Roberts A
    Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
    Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-11102.
    PubMed     Abstract available


  412. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
    ASO Visual Abstract: Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment to Reliably Exclude Residual Cancer in Breast Cancer Patients.
    Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-10958.
    PubMed    


  413. MITTAL A, Deo S, Gogia A, Batra A, et al
    ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
    Ann Surg Oncol. 2021 Nov 25. pii: 10.1245/s10434-021-10967.
    PubMed    


  414. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
    The Breast Cancer Patient Experience of Telemedicine During COVID-19.
    Ann Surg Oncol. 2021 Nov 24. pii: 10.1245/s10434-021-11103.
    PubMed     Abstract available


  415. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
    ASO Visual Abstract: A Single Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11038.
    PubMed    


  416. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
    Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11088.
    PubMed     Abstract available


  417. FU M, Chen Q, Zeng L, Hong T, et al
    Prognosis Comparison Between Nipple-Sparing Mastectomy and Total Mastectomy in Breast Cancer: A Case-Control Study After Propensity Score Matching.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11044.
    PubMed     Abstract available


  418. MATAR R, Gemignani ML
    ASO Author Reflections: Stage IV Pregnancy-Associated Breast Cancer: A Continuum of Disease.
    Ann Surg Oncol. 2021 Nov 19. pii: 10.1245/s10434-021-11018.
    PubMed    


  419. VERBUS EA, Rossi AJ, Clark AS, Taunk NK, et al
    Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer.
    Ann Surg Oncol. 2021 Nov 16. pii: 10.1245/s10434-021-10987.
    PubMed    


  420. SARIDAKIS A, Berger ER, Greenup R, Golshan M, et al
    ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10649.
    PubMed    


  421. ELMORE LC, Kuerer HM, Barcenas CH, Smith BD, et al
    ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10579.
    PubMed    


  422. ADESOYE T, Babayemi O, Postlewait LM, DeSnyder SM, et al
    ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10586.
    PubMed    


  423. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
    Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
    Ann Surg Oncol. 2021 Nov 5. pii: 10.1245/s10434-021-11007.
    PubMed     Abstract available


  424. BHUTIANI N, Holland MM, Mercer MK, Donaldson M, et al
    Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost.
    Ann Surg Oncol. 2021;28:7432-7438.
    PubMed     Abstract available


  425. KLASSEN AF, Kaur MN, Tsangaris E, de Vries CEE, et al
    Development and Psychometric Validation of BREAST-Q Scales Measuring Cancer Worry, Fatigue, and Impact on Work.
    Ann Surg Oncol. 2021;28:7410-7420.
    PubMed     Abstract available


  426. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
    Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
    Ann Surg Oncol. 2021;28:7404-7409.
    PubMed     Abstract available


  427. TSANGARIS E, Klassen AF, Kaur MN, Voineskos S, et al
    Development and Psychometric Validation of the BREAST-Q Sensation Module for Women Undergoing Post-Mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2021;28:7842-7853.
    PubMed     Abstract available


  428. LAI HW
    ASO Author Reflections: Oncologic Outcome of Endoscopic-Assisted Breast Surgery Compared with the Conventional Approach in Breast Cancers.
    Ann Surg Oncol. 2021;28:7381-7382.
    PubMed    


  429. BHUTIANI N, Ajkay N
    ASO Author Reflections: The Broad Impact of the Margin Consensus Guidelines for Breast-Conserving Surgery in DCIS.
    Ann Surg Oncol. 2021;28:7439-7440.
    PubMed    


  430. CHAGPAR AB
    Guide to Enhanced Recovery for Cancer Patients Undergoing Breast Surgery and Reconstruction.
    Ann Surg Oncol. 2021;28:6943-6946.
    PubMed    


    October 2021
  431. MYERS SP, Ahrendt GM, Lee JS, Steiman J, et al
    ASO Visual Abstract: Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Oct 29. pii: 10.1245/s10434-021-10255.
    PubMed    


  432. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
    ASO Visual Abstract: The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer 10 Years After the ACOSOG Z0011 Trial First Publication.
    Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10939.
    PubMed    


  433. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
    Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
    Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10901.
    PubMed     Abstract available


  434. ASCHA M, Felt D, Beach LB, Kulkarni SA, et al
    ASO Author Reflections: Constructing a Transgender and Nonbinary Cohort to Analyze Breast Cancer Screening.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10978.
    PubMed    


  435. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10942.
    PubMed    


  436. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
    A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Ann Surg Oncol. 2021 Oct 26. pii: 10.1245/s10434-021-10932.
    PubMed     Abstract available


  437. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
    ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2021 Oct 21. pii: 10.1245/s10434-021-10898.
    PubMed    


  438. KHAN TM, Rossi AJ, Suman V, Haffty B, et al
    Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2021 Oct 20. pii: 10.1245/s10434-021-10830.
    PubMed    


  439. STAHL K, Dodge D, Shen C
    Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit: Author's Reply.
    Ann Surg Oncol. 2021 Oct 18. pii: 10.1245/s10434-021-10906.
    PubMed    


  440. HERREMANS KM, Cribbin MP, Riner AN, Neal DW, et al
    ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Ann Surg Oncol. 2021 Oct 16. pii: 10.1245/s10434-021-10648.
    PubMed    


  441. MITTAL A, Pramanik R
    ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
    Ann Surg Oncol. 2021 Oct 15. pii: 10.1245/s10434-021-10880.
    PubMed     Abstract available


  442. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
    Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2021 Oct 13. pii: 10.1245/s10434-021-10809.
    PubMed     Abstract available


  443. MURALI-NANAVATI S, Nair NS, Badwe R
    Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit.
    Ann Surg Oncol. 2021 Oct 11. pii: 10.1245/s10434-021-10887.
    PubMed    


  444. DESNYDER SM, Yi M, Boccardo F, Feldman S, et al
    ASO Visual Abstract: American Society of Breast Surgeons Practice Patterns for Patients At-risk and Affected by Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10608.
    PubMed    


  445. DELIERE A, Attai D, Victorson D, Kuchta K, et al
    ASO Visual Abstract: Decision Regret About Breast Cancer Surgery-The WhySurg Study: Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Found to Have Lowest Levels of Regret.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10591.
    PubMed    


  446. OROZCO JIJ, Grumley JG
    ASO Author Reflections: Molecular Testing in Breast Cancer: Is Core Biopsy Equivalent to Surgical Specimen?
    Ann Surg Oncol. 2021 Oct 4. pii: 10.1245/s10434-021-10604.
    PubMed    


  447. MITTAL A, Deo SVS, Gogia A, Batra A, et al
    Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
    Ann Surg Oncol. 2021 Oct 2. pii: 10.1245/s10434-021-10870.
    PubMed     Abstract available


  448. BUTLER PD, Morris MP, Momoh AO
    Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation.
    Ann Surg Oncol. 2021;28:6099-6108.
    PubMed     Abstract available


  449. BYUN DJ, Wu SP, Nagar H, Gerber NK, et al
    Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use.
    Ann Surg Oncol. 2021;28:6083-6096.
    PubMed     Abstract available


  450. MOO TA, Saccarelli CR, Sutton EJ, Sevilimedu V, et al
    Tumor-Nipple Distance of >/= 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2021;28:6024-6029.
    PubMed     Abstract available


  451. SHAH C, Bremer T, Cox C, Whitworth P, et al
    The Clinical Utility of DCISionRT((R)) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
    Ann Surg Oncol. 2021;28:5974-5984.
    PubMed     Abstract available


  452. GORDON NT, Alberty-Oller JJ, Fei K, Greco G, et al
    Association of Insulin Resistance and Higher Oncotype DX Recurrence Score.
    Ann Surg Oncol. 2021;28:5941-5947.
    PubMed     Abstract available


  453. VAN LA PARRA RFD, Clough KB, Thygesen HH, Levy E, et al
    Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis.
    Ann Surg Oncol. 2021;28:5920-5928.
    PubMed     Abstract available


  454. HILLS N, Leslie M, Davis R, Crowell M, et al
    Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
    Ann Surg Oncol. 2021;28:5895-5905.
    PubMed     Abstract available


  455. MUKHTAR RA, Hoskin TL, Habermann EB, Day CN, et al
    Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
    Ann Surg Oncol. 2021;28:5867-5877.
    PubMed     Abstract available


  456. RELATION T, Obeng-Gyasi S, Bhattacharyya O, Li Y, et al
    Racial Differences in Response to Neoadjuvant Chemotherapy: Impact on Breast and Axillary Surgical Management.
    Ann Surg Oncol. 2021;28:6489-6497.
    PubMed     Abstract available


  457. ILES K, Downs-Canner S
    ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10747.
    PubMed    


  458. MOO TA, Sacchini V
    ASO Author Reflections: Tumor-Nipple Distance of >/= 1 cm on Pre- or Post-Neoadjuvant Chemotherapy Imaging can be used to Determine Eligibility for Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2021;28:6030-6031.
    PubMed    


  459. WEISS A, Golshan M, Ollila DW
    ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies.
    Ann Surg Oncol. 2021;28:5972-5973.
    PubMed    


  460. GORDON N, Alberty-Oller J
    Genomic Assays and the Great Unknown: The Oncotype DX May Miss the Mark in Certain Populations.
    Ann Surg Oncol. 2021;28:5948-5949.
    PubMed    


  461. SCHWARTZ T
    Just Say No: The Case Against Opioid-Based Postoperative Pain Management Regimens Following Breast Surgery.
    Ann Surg Oncol. 2021;28:5799-5800.
    PubMed    


  462. ELDREDGE-HINDY H
    ASO Author Reflections: Five-Fraction Whole-Breast Radiation: Let's Make Adjuvant Therapy Accessible.
    Ann Surg Oncol. 2021;28:5893-5894.
    PubMed    


  463. MUKHTAR RA, Boughey JC
    ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.
    Ann Surg Oncol. 2021;28:5878-5879.
    PubMed    


  464. HILLS N, Leslie M, Davis R, Crowell M, et al
    ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?
    Ann Surg Oncol. 2021;28:5906.
    PubMed    


  465. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10864.
    PubMed    


    September 2021
  466. BREDBECK BC, Dossett LA
    ASO Author Reflections: Adding up the Costs of Low-Value Breast Cancer Care.
    Ann Surg Oncol. 2021 Sep 29. pii: 10.1245/s10434-021-10863.
    PubMed    


  467. GONZALEZ L, Sun C, Loscalzo M, Clark K, et al
    A Cross-Sectional Study of Distress Levels in Patients with Newly Diagnosed Breast Cancer: The Impact of Race, Ethnicity, and Language Preference.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10561.
    PubMed     Abstract available


  468. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
    Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10847.
    PubMed     Abstract available


  469. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
    The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer-10 Years after the ACOSOG Z0011 Trial First Publication.
    Ann Surg Oncol. 2021 Sep 27. pii: 10.1245/s10434-021-10812.
    PubMed     Abstract available


  470. MILLEN EC, Cavalcante FP
    ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10836.
    PubMed    


  471. ASGEIRSSON KS, Dixon JM, Darrigues L, Sarfati B, et al
    Multicenter Evaluation of Hydrodissection-Assisted Mastectomy (HAM).
    Ann Surg Oncol. 2021;28:4780-4781.
    PubMed    


  472. SCHAVERIEN MV, Chang EI
    Discussion: "Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: LYMPH-Q Upper Extremity Module".
    Ann Surg Oncol. 2021;28:4767-4768.
    PubMed    


  473. TUTTLE TM, Burke EE, Hui JYC
    Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
    Ann Surg Oncol. 2021;28:4764-4766.
    PubMed    


  474. MCCORMICK PJ, Simon BA
    ASO Author Reflections: We No Longer Give Ketorolac During Mastectomy. Should You?
    Ann Surg Oncol. 2021;28:5141.
    PubMed    


  475. FRIEDRICH AU, Lannin DR
    ASO Author Reflections: Breast Angiosarcoma-A Rare Disease with a Lot of Uncertainty.
    Ann Surg Oncol. 2021;28:5119-5120.
    PubMed    


  476. TADROS AB, Sevilimedu V, Plitas G
    Reply to: Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?
    Ann Surg Oncol. 2021;28:5440-5441.
    PubMed    


  477. CORSO G
    Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst?
    Ann Surg Oncol. 2021;28:5438-5439.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: